Navellier & Associates’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.11M | Sell |
47,593
-20,519
| -30% | -$2.2M | 0.63% | 44 |
|
|
2025
Q1 | $7.1M | Buy |
68,112
+63,142
| +1,270% | +$6.58M | 0.98% | 23 |
|
|
2024
Q4 | $444K | Hold |
4,970
| – | – | 0.05% | 245 |
|
|
2024
Q3 | $416K | Hold |
4,970
| – | – | 0.06% | 244 |
|
|
2024
Q2 | $383K | Hold |
4,970
| – | – | 0.04% | 271 |
|
|
2024
Q1 | $340K | Buy |
4,970
+250
| +5% | +$17.1K | 0.04% | 278 |
|
|
2023
Q4 | $273K | Buy |
+4,720
| New | +$273K | 0.04% | 285 |
|
|
2014
Q3 | – | Sell |
-31,244
| Closed | -$399K | – | 328 |
|
|
2014
Q2 | $399K | Sell |
31,244
-4,929
| -14% | -$62.9K | 0.02% | 216 |
|
|
2014
Q1 | $489K | Sell |
36,173
-352
| -1% | -$4.76K | 0.02% | 180 |
|
|
2013
Q4 | $439K | Buy |
+36,525
| New | +$439K | 0.02% | 197 |
|